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Wednesday, February 11, 2015 579achannels (LTCC) has been reported in hypertrophy and heart failure. We hy-
pothesize that the altered expression of the Cavb subunits in cardiac hypertro-
phy and heart failure results in the altered coupling and regulation of ICa,T. We
found an increase in the Cavb1 and Cavb3 mRNA and Cavb2 and Cavb4 sub-
unit isoform at the protein level in mouse ventricles in a transthoracic aortic
constriction (TAC) induced pathological cardiac hypertrophy model. Whole-
cell patch clamp electrophysiology using transiently transfected HEK293 cells
revealed that co-expression of Cavb1 or Cavb2 with Cav3.2 channel isoform
resulted in a significant increase in peak ICav3.2 and a rightward shift in the
V1/2 of activation and significantly slower inactivation of ICav3.2. On the other
hand, co-expression of Cavb3 or Cavb4 significantly reduced the peak ICav3.2.
In contrast, co-expression of Cavb isoforms did not alter ICav3.1. Furthermore,
co-immunoprecipitation studies in transiently transfected HEK293 cells also
demonstrated that the Cav3.2 channel separately co-immunoprecitated with
anti-Cavb1 or anti-Cavb2 antibody. In conclusion, our data suggest that the
Cavb1 and Cavb2 subunits of the LTCC may regulate ICav3.2 in cardiomyocytes
during pathological cardiac hypertrophy.
2927-Pos Board B357
Homologous Serine/Threonine in the CaV 2.2a1 and 2.3a1 Subunits Behave
Similarly, as Stimulatory and Inhibitory PKC Sites
Ganesan L. Kamatchi.
Biology, Norfolk State University, Norfolk, VA, USA.
High voltage-gated calcium (Cav) channels are regulated by PKC isozymes.
These isozymes target selected serine/threonine (Ser/Thr) PKC phosphoryla-
tion sites in the intracellular regions of Cava1 subunits of these channels. It
has been found earlier using Cav2.2a1 subunits that stimulatory (Thr-422,
Ser-2108 and Ser-2132) and inhibitory (Ser-425) PKC sites exist and their
activation with PKC isozymes led to potentiation and depression of calcium
currents (ICa) respectively. Based on the above report, it was planned to
examine if the homologous sites in the Cav2.3a1 subunits behave similarly.
In this regard the WT Cav2.3a1 or Ser/Thr Ala mutants of stimulatory
(Thr-365, Ser-1995 and Ser-2011) or inhibitory (Ser-369) sites were expressed
along with b1b and 2/d cDNA subunits in Xenopus oocytes and the barium cur-
rents (IBa) were studied. Intracellular injection of PKC isozymes bII or ε
potentiated WT Cav2.3 currents. While both PKC bII and ε potentiated IBa
through Thr-365 (T365/S369A/S1995A/S2011A), only PKC ε increased IBa
through Ser-1995 (T365A/S369A/S1995/S2011A) channels. Ser-2011 failed
to act as a stimulatory site contrary to its homologous site, Ser-2132 in the
Cav2.2a1 subunits. However, Ser-369 acted as inhibitory site as its homolog
Ser-425 in the Cav2.2a1 subunits. Both PKC bII and ε inhibited IBa through
Ser-369 (T365A/S369/S1995A/S2011A) channels. When both Thr-365 and
Ser-369 were present (T365/S369/S1995A/S2011A), IBa was neither stimu-
lated nor inhibited. However, stimulation was dominant when two stimulatory
sites (Thr-365 & Ser-1995) were present along with Ser-369. Experiments
with other mutants, including Ser/Thr Asp constructs are being studied and
will be discussed.
2928-Pos Board B358
Norepinephrine Upregulates T-Type Calcium Channels in Rat Pinealo-
cytes
Haijie Yu1, Jong Bae Seo1, Seung-Ryoung Jung1, Duk-Su Koh1,2,
Bertil Hille1.
1Physiology and Biophysics, University of Washington, Seattle, WA, USA,
2Physics, Pohang University of Science and Technology, Pohang, Korea,
Republic of.
The mammalian pineal has a circadian rhythm of melatonin secretion at night
triggered by norepinephrine (NE) released from sympathetic nerve terminals.
We asked whether functional expression of voltage-gated calcium channels in
rat pinealocytes is changed by culturing them in NE as a surrogate for the
night signal. Channel activity was assayed as ionic currents under patch
clamp. Cultured without NE, pinealocytes showed only non-inactivating L-
type dihydropyridine-sensitive calcium current. After 24 h in NE, an addi-
tional low-voltage activated transient calcium current developed whose phar-
macology and kinetics corresponded to a T-type channel. This change was
initiated by b-adrenergic receptors, cyclic AMP, and protein kinase A as re-
vealed by pharmacological experiments. Quantitative PCR experiments
showed mRNA for Cav1.4 (L-type), Cav3.1 and Cav3.2 (both T-type).
Cav3.1 T-type channel mRNA was significantly elevated by culture in NE,
but those for Cav1.4 and Cav3.2 were not. After only 8 h of NE treatment,
Cav3.1 mRNA was already elevated, but the transient calcium current was
not. Even a 16 h wait without NE following the 8 h NE treatment induced lit-
tle additional transient current. However, these cells were primed to make
transient current after a second NE exposure. Induction of transient currentwas sensitive to the inhibitors of intracellular protein trafficking. The NE-
induced T-type channel mediated an increased calcium entry during short de-
polarizations and supported modest transient electrical responses to depolariz-
ing stimuli. Such experiments reveal a potential for circadian regulation of
pinealocyte electrical excitability and calcium signaling. This work is sup-
ported by National Institutes of Health grants GM-83913, NS-08174 and
DK-080840.
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Cav1.3 channels belong to the family of the voltage-gated L-type calcium chan-
nels. Because of activation at low voltage thresholds, Cav1.3 channels are
involved in regulation of the cell firing but they are also linked to the generation
of the oxidative stress. Calcium-dependent inactivation (CDI) is a negative
feedback process terminating the potentially toxic calcium influx (Johny et
al., Nat Commun 2013;4:1717). Multiple Cav1.3 splice isoforms, which can
be simultaneously expressed in the same tissue, differ in their channel gating
and CDI (Bock et al., J Biol Cem 2011;286:42736).
We applied single-channel patch-clamp measurements to compare two native
isoforms with alternatively spliced C-terminus. Cav1.3 42 isoform has a long
C-terminus containing C-terminal modulator domain (CTM), whereas in the
short C-terminus of Cav1.3 42A isoform CTM is truncated. CTM shifts channel
activation to higher voltages and inhibits CDI.
Here, we observed that calcium influx from a few single-channel openings lead
to CDI, visible as a decay of the average single-channel current. However, the
extent of CDI was significantly reduced in Cav1.3 42 isoform as compared with
42A isoform. Furthermore, we observed the shortening of the open times as a
result of CDI (Imredy and Yue, Neuron 1994;12:301). The degree of the open-
time shortening was dependent on the prior calcium influx (Josephson et al.,
J Physiol 2010;588:213) with a steeper dependence for Cav1.3 42A isoform.
Additionally, we performed experiments with a channel agonist S(-)BayK
8644. The boosting of the channel activity by BayK 8644 eliminated the differ-
ence between the isoforms, resulted in a high extent of CDI for both splice
variants.
Our findings suggest the ability of CTM to inhibit CDI depends on the channel
activity, which can be in turn modified by CTM.
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T-type Calcium channels play a critical role in regulating neuronal excit-
ability and modulating sensory transmission. The Cav3.2 channel isoform
is highly expressed in peripheral nociceptors as well as in the pain-
processing regions of the dorsal horn of the spinal cord. Augmenting
Cav3.2 currents has been shown to induce hyperexcitability in nociceptive
neurons in vitro and hyperalgesia in vivo. These studies strongly suggest
that potentiation of the Cav3.2 channel results in abnormal nociceptive trans-
mission, which could contribute to a variety of clinical pain syndromes.
Therefore, it is important to identify endogenously produced molecular spe-
cies that modulate Cav3.2 currents. Using the patch-clamp technique and sta-
bly transfected human embryonic kidney cells (HEK-293) expressing the
Cav3.2 channel, we have begun to characterize a factor found in fetal bovine
serum (FBS) that profoundly affects Cav3.2 channel gating kinetics. Specif-
ically, when compared to baseline recombinant currents, 1% serum produces
maximal increases in current magnitude (350%; p<.001), conductance
(150%, p<.001), rate of macroscopic inactivation (47.1%; p<.001) and deac-
tivation (74.3%; p<.001). Furthermore, 1% serum induces a hyperpolarizing
shift in voltage-dependence of activation (V50) (4.77mV; p <.001) with
minimal effect on voltage-dependence of inactivation. In contrast, we found
that recombinant CaV3.1 currents were completely insensitive. Similar to re-
combinant Cav3.2 currents, T-currents from rat dorsal root ganglia (DRG)
cells exhibited comparable changes, with 1% serum producing maximal in-
creases in current magnitude (210%; p<.05), conductance (183%; p<.05),
and rate of inactivation (71.4%; p<.001), in addition to inducing a hyperpo-
larizing shift in V50 (9.402mV; p<.01). Future studies will focus on iden-
tifying this serum factor in order to evaluate its potential role in nociceptive
signal modulation and cellular excitability. Supported in part by NIH grant
R21DA034448 (SMT).
